Plain-English translation of NCT03103932 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
When you're admitted to the hospital for heart failure that's gotten worse, doctors need to decide when you're ready to go home safely. This study tests whether a blood test called NTproBNP can help guide that decision. The test measures a protein in your blood that shows how hard your heart is working, and researchers want to see if using this information helps patients recover better and know when it's safe to discharge.
Right now, doctors don't always have a clear, consistent way to decide when a heart failure patient is stable enough to leave the hospital. Some patients may go home too early and end up back in the emergency room, while others might stay longer than needed. This study is testing whether the blood test can help doctors make smarter, safer decisions about discharge timing.
You likely qualify if…
You likely don't qualify if…
You'll be randomly assigned to one of two groups. One group receives usual care with standard discharge decisions. The other group has their blood test results used to guide a specific discharge pathway—doctors will check your blood test on days 2–3 and before you leave, and use those results to decide when you're ready to go home safely. All participants complete a quality of life questionnaire when admitted and again 30 days after discharge. The study team will stay in touch with you during this time.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
Canada